Synthesis of Novel 2′,3′-Difluorinated 5′-Deoxythreosyl Phosphonic Acid Nucleosides as Antiviral Agents

REFERENCES

• Richman, D.D.; Fischl, M.A.; Grieco, M.H.; Gottlieb, M.S.; Volberding, P.A.; Laskin, O.L.; Leedom, J.M.; Groopman, J.E.; Mildvan, D.; Hirsch, M.S.; Jackson, G.G.; Durack, D.T.; Phil, D.; Lusinoff-Lehrman, S. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N. Engl. J. Med. 1987, 317, 192–197;
   PubMed Web of Science ®Google Scholar
• Starnes, M.C.; Cheng, Y.C. Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J. Biol. Chem. 1987, 262, 988–991;
   PubMed Web of Science ®Google Scholar
• Lambert, J.S.; Seidlin, M.; Reichman, R.C.; Plank, C.S.; Laverty, M.; Morse, G.D.; Knupp, C.; McLaren, C.; Pettinelli, C.; Valentine, F.T.; Dolin, R. 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. N. Engl. J. Med. 1990, 322, 1333–1340.
   PubMed Web of Science ®Google Scholar
• Boojamra, C.G.; Mackman, R.L.; Markevitch, D.Y.; Prasad, V.; Ray, A.S.; Douglas, J.; Grant, D.; Kim, C.U.; Cihlar, T. Synthesis and anti-HIV activity of GS-9148 (2′-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor. Bioorg. Med. Chem. Lett. 2008, 18, 1120–1123;
   PubMed Web of Science ®Google Scholar
• Cihlar, T.; Ray, A.S.; Boojamra, C.G.; Zhang, L.; Hui, H.; Laflamme, G.; Vela, J.E.; Grant, D.; Chen, J.; Myrick, F.; White, K.L.; Gao, Y.; Lin, K.Y.; Douglas, J.L.; Parkin, N.T.; Carey, A.; Pakdaman, R.; Mackman, R.L. Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. Antimicrob. Agents Chemother. 2008, 52, 655–665.
   PubMed Web of Science ®Google Scholar
• Owen, G.R.; Verheyden, J.P.H.; Moffatt, J.G. Synthesis of some 4′-fluoridine derivatives. J. Org. Chem. 1976, 41, 3010–3017;
   PubMed Web of Science ®Google Scholar
• Maguire, A.R.; Meng, W.D.; Roberts, S.M.; Willetts, A.J. Synthetic approaches towards nucleocidin and selected analogues; anti-HIV activity in 4′-fluorinated nucleoside derivatives. J. Chem. Soc., Perkin Trans, 1 1993
   Google Scholar
• Borthwick, A.D.; Biggadike, K.; Paternoster, I.L.; Coates, J.A.V.; Knight, D.J. The synthesis and antiviral activity of 4′-hydroxy and 4′-fluorocarbocyclic-2′-deoxyguanosines. Bioorg. Med. Chem. Lett. 1993, 3, 2577–2580;
   Web of Science ®Google Scholar
• Gumina, G.; Chong, Y.; Choi, Y.; Chu, C.K. Stereoselective synthesis of carbocyclic L-4′-fluoro-2′,3′-dideoxyadenosine. Org. Lett. 2000, 2, 1229–1231.
   PubMed Web of Science ®Google Scholar
• Borthwick, A.D.; Biggadike, K.; Paternoster, I.L.; Coates, J.A.V.; Knight, D.J. The synthesis and antiviral activity of 4′-hydroxy and 4′-fluorocarbocyclic-2′-deoxyguanosines. Bioorg. Med. Chem. Lett. 1993, 3, 2577–2580;
   Web of Science ®Google Scholar
• Gumina, G.; Chong, Y.; Choi, Y.; Chu, C.K. Stereoselective synthesis of carbocyclic L-4′-fluoro-2′,3′-dideoxyadenosine. Org. Lett. 2000, 2, 1229–1231.
   PubMed Web of Science ®Google Scholar
• Hong, J.H.; Lee, K.; Choi, Y.; Chu, C.K. Enantiomeric synthesis of 3′-fluoro-apionucleosides using Claisen rearrangement. Tetrahedron Lett. 1998, 39, 3443–3446
   Web of Science ®Google Scholar
• Jeong, B.S.; Lee, J.W.; Son, H.J.; Kim, B.Y.; Ahn, S.K. Asymmetric synthesis of 2′,3′-dideoxy-3′-fluoroapiofuranosyl nucleosides. Terahedron; Asymmetry 2005, 16, 3795–3801.
   Web of Science ®Google Scholar
• Vina, D.; Wu, T.; Renders, M.; Laflamme, G.; Herdewijn, P. Synthesis of 3′-O-phosphonomethyl nucleosides with an adenine base moiety. Tetrahedron 2007, 63, 2634–2646.
   Web of Science ®Google Scholar
• Kang, L.; Kim, E.; Choi, E.J.; Yoo, J.C.; Lee, W.; Hong, J.H. Synthesis and conformation of novel 4′-fluorinated 5′-deoxythreosyl phosphonic acid nucleosides as antiviral agents. Bull. Korean Chem. Soc. 2012, 33, 4007–4014.
   Web of Science ®Google Scholar
• Schöning, K.; Scholz, P.; Guntha, S.; Wu, X.; Krishnamurthy, R.; Eschenmoser, A. Chemical etiology of nucleic acid structure: The alpha-threofuranosyl-(3′→2′) oligonucleotide system. Science 2000, 5495, 1347–1351.
   Web of Science ®Google Scholar
• De Clercq, E. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: The magic of the phosphonate bond. Biochem. Pharmacol. 2011, 82, 99–109.
   PubMed Web of Science ®Google Scholar
• Balzarini, J.; Hao, Z.; Herdewijn, P.; Johns, D.G.; De Clercq, E. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Proc. Natl. Acad. Sci U S A. 1991, 88, 1499–1503;
   PubMed Web of Science ®Google Scholar
• Magee, W.C.; Aldern, K.A.; Hostetler, K.Y.; Evans, D.H. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand. Antimicrob. Agents Chemother. 2008, 52, 586–597.
   PubMed Web of Science ®Google Scholar
• Wu, T.; Froeyen, M.; Kempeneers, V.; Pannecouque, C.; Wang, J.; Busson, R.; De Clercq, E.; Herdewijn, P. Deoxythreosyl phosphonate nucleosides as selective anti-HIV agents. J. Am. Chem. Soc. 2005, 127, 5056–5065.
   PubMed Web of Science ®Google Scholar
• Koh, Y.H.; Shim, J.H.; Wu, J.Z.; Zhong, W.; Hong, Z.; Girardet, J.L. Design, synthesis, and antiviral activity of adenosine 5′-phosphonate analogues as chain terminators against hepatitis C virus. J. Med. Chem. 2005, 48, 2867–2875.
   PubMed Web of Science ®Google Scholar
• Kim, C.U.; Luh, B.Y.; Misco, P.F.; Bronson, J.J.; Hitchcock, M.J.; Ghazzouli, I.; Martin, J.C. Acyclic purine phosphonate analogues as antiviral agents. Synthesis and structure-activity relationships. J. Med. Chem. 1990, 33, 1207–1213.
   PubMed Web of Science ®Google Scholar
• Patrick, T.B.; Lanahan, M.V.; Yang, C.; Walker, J.K. New fluorobutenolide templates for synthesis. J. Org. Chem. 1994, 59, 1210–1212;
   Web of Science ®Google Scholar
• Morikawa, T.; Sasaki, H.; Mori, K.; Shiro, M.; Taguchi, T. Simmons-Smith reactions of fluoroallyl alcohol derivatives. Chem. Pharm. Bull. 1992, 40, 3189–3193.
   Web of Science ®Google Scholar
• McAtee, J.J.; Schinazi R.F.; Liotta, D.C. A completely diastereoselective electrophilic fluorination of a chiral, noncarbohydrate sugar ring precursor: Application to the synthesis of several novel 2′-fluoronucleosides. J. Org. chem. 1998, 63, 2161–2167.
   Web of Science ®Google Scholar
• Kumamoto, H.; Topalis, D.; Broggi, J.; Pradere, U.; Roy, V.; Berteina-Raboin, S.; Nolan, S.P.; Deville-Bonne, D.; Andrei, G.; Snoeck, R.; Garin, D.; Crance, J.-M.; Agrofoglio, L.A. Preparation of acyclonucleoside phosphonate analogues based on cross-metathesis. Tetrahedron 2008, 64, 3517–3526;
   Web of Science ®Google Scholar
• Montagu, A.; Pradere, U.; Roy, V.; Nolan, S.P.; Agrofoglio, L.A. Expeditious convergent procedure for the preparation of bis(POC) prodrug of new (E)-4-phosphono-but-2-en-yl nucleosides. Tetrahedron 2011, 67, 5317–5328;
   Web of Science ®Google Scholar
• Huang, Q.; Herdewijn, P. Synthesis of (E)-3′-phosphonoalkenyl modified nucleoside phosphonates via a highly stereoselective olefin cross-metathesis reaction. J. Org. Chem. 2011, 76, 3742–3753.
   PubMed Web of Science ®Google Scholar
• Scholl, M.; Ding, S.; Lee, C.W.; Grubbs, R.H. Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimethyl-4,5-dihydroimidazole-2-ylidene ligands. Org. Lett. 1999, 1, 953–956.
   PubMed Web of Science ®Google Scholar
• Hocková, D.; Holý, A.; Masojídková, M.; Keough, D.T.; De Jersey, J.; Guddat, L.W. Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase. Bioorg. Med. Chem. 2009, 17, 6218–6232;
   PubMed Web of Science ®Google Scholar
• Bronson, J.J.; Ghazzouli, I.; Hitchocock, M.J.M.; Webb, R.R.; Martin, J.C. Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. J. Med. Chem. 1989, 32, 1457–1463.
   PubMed Web of Science ®Google Scholar
• Robins, M.J.; Uznanski, B. Non-aqueous diazotization with t-butyl nitrite. Introduction of fluorine, chlorine, and bromine at C-2 of purine nucleoside. Can. J. Chem. 1981, 59, 2608–2611.
   Web of Science ®Google Scholar
• Vorbruggen, H.; Ruh-Pohlenz, C. Handbook of Nucleoside Synthesis, John Wiley & Sons, Inc., New York, 2001.
   Google Scholar
• Montgomery, J.; Hewson, K. Nucleosides of 2-fluoroadenine. J. Med. Chem. 1969, 12, 498–504.
   PubMed Web of Science ®Google Scholar
• Tong, G.L.; Ryan, K.J.; Lee, W.W.; Acton, E.M. Goodman, L. Nucleosides of thioguanine and other 2-amino-6-substituted purines from 2-acetamido-5-chloropurine. J. Org. Chem. 1967, 32, 859–862.
   PubMed Web of Science ®Google Scholar
• Holy, A.; Votruba, I.; Merta, A.; Cerny, J.; Vesely, J.; Vlach, J.; Sediva, K.; Rosenberg, I.; Otmar, M.; Hrebabecky, H.; Travniekb, M.; Vonkac, V.; Snoeck, R.; De Clercq, E. Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Res. 1990, 13, 295–311.
   PubMed Web of Science ®Google Scholar
• Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 1988, 20, 309–321.
   PubMed Web of Science ®Google Scholar
• All geometries were optimized with the framework of the density functional theory (DFT), with Spartan modeling software. The B3LYP functional with 6-31G* basis set was employed.
   Google Scholar